New Research by Oxford Economics Finds US Malaria Funding Boosted Economies More Than $90 Billion
From 2003 to 2023, the US disbursed a total of $15.6 billion for malaria control allocated through the Global Fund and the President’s Malaria Initiative, averting 646.4 million malaria cases. …
Malaria Know More: A Discussion with Malaria Researchers on the Role of Artificial Intelligence
In a discussion with Malaria No More, Dr. Alfred Andama (Makerere AI Health Lab) and Dr. Mohammad Yaqub (MBZUAI) talk about the role of artificial intelligence in combating malaria. Dr.…
Malaria No More Testifies Before House Appropriations Subcommittee on How U.S. Funding for Malaria Programs Makes America Safer, Stronger, and More Prosperous
April 2, 2025 (Washington, DC) - Today, Spencer Knoll, Malaria No More’s Director of U.S. Policy and Advocacy, delivered testimony before the House Appropriations Committee on National Security, Department of…
Malaria Know More: A Discussion with NIH Researcher, Dr. Joshua Tan, on Discovering Novel Class of Anti-malaria Antibodies
In a discussion with Malaria No More, Dr. Joshua Tan talks about a new study at the National Institutes of Health (NIH) that identified a novel class of antibodies that…
Malaria No More Statement on the Administration’s Termination of USAID Malaria Programs
February 27, 2025 (Washington, DC) – Malaria No More CEO Martin Edlund issued the following statement upon the U.S. Department of State’s termination of 90% of USAID contracts, including contracts…
Malaria Know More: A conversation with Duke University Professor, Wendy O’Meara, on Kenya’s First Seasonal Malaria Chemoprevention (SMC) Pilot Program
In a discussion with Malaria No More, Professor Wendy O’Meara of Duke University, a lead malaria researcher, shares the results of Kenya’s first-ever Seasonal Malaria Chemoprevention (SMC) pilot project conducted…
Malaria Know More: A discussion with Sanaria CEO, Dr. Stephen L. Hoffman, on developing a potentially groundbreaking single-dose malaria vaccine
In a discussion with Malaria No More, Dr. Stephen Hoffman, CEO of biotechnology company Sanaria, discusses his company’s latest progress toward a single-dose malaria vaccine with the development of Sanaria®PfSPZ-LARC2…
Malaria No More Statement on the State Department’s Waiver for Lifesaving Malaria Services to Resume
February 7, 2025 (Washington, DC) – Malaria No More CEO Martin Edlund issued the following statement upon the release of a waiver from the U.S. Department of State for critical…
Malaria No More Statement on the 2024 World Malaria Report
December 11, 2024 (Washington, DC) - Malaria No More CEO Martin Edlund issued the following statement upon the release of the World Health Organization’s (WHO) 2024 World Malaria Report. This…
Malaria Know More: A discussion with Harvard Professor, Marcia Castro, on how deforestation promotes the spread of malaria
In a discussion with Malaria No More, Marcia Castro, Andelot Professor of Demography and chair of the Department of Global Health and Population at Harvard T.H. Chan School of Public…
ASTMH Annual Meeting: Experts Address Malaria Challenges & Solutions
In New Orleans – a city where early epidemics of yellow fever, cholera, and malaria produced the first school of public health and first school of tropical medicine in the…
Malaria Know More: NIH’s Dr. Bob Seder discusses new tools & technologies for ending malaria
In a discussion with Malaria No More, Dr. Robert Seder, Chief of the Cellular Immunology Section in the Vaccine Research Center in the National Institute of Allergy and Infectious Diseases, NIH,…
